Form 4: Core Scientific Executive Executes Stock Sale

Chief Legal and Administrative Officer Todd DuChene sold 10,000 shares of Core Scientific common stock via a 10b5-1 plan.

Summary

• Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc., sold a total of 10,000 shares of common stock on June 8, 2026.
• The sales were executed in two tranches: 5,500 shares at a weighted average price of $26.6376 and 4,500 shares at a weighted average price of $27.1053.
• Following these transactions, the reporting person retains beneficial ownership of 2,068,895 shares of common stock.
• The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed under a pre-existing 10b5-1 plan and represents a small fraction of the executive's total holdings.

Positives

• The sale was pre-planned under a Rule 10b5-1 trading plan, which typically indicates the transaction is for personal financial management rather than a reaction to non-public information.

Negatives

• The sale represents a reduction in the executive's direct equity stake in the company.

Risks

• Continued insider selling can sometimes be perceived negatively by retail investors, potentially impacting short-term market sentiment.

Future Outlook

No forward-looking guidance or operational outlook was provided in this filing.

Management Comments

• The reporting person has committed to providing full information regarding the number of shares sold at each separate price within the reported ranges upon request.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives in the volatile cryptocurrency mining and data center infrastructure sector to diversify personal holdings.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate officers to avoid allegations of insider trading while liquidating equity compensation.

Stakeholder Impact

• Minimal impact expected as the sale was pre-planned and represents a small portion of the executive's total ownership.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Core Scientific, CORZ, Insider Trading, Form 4, Stock Sale, Todd DuChene